London, United Kingdom

James Lumley




Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of James Lumley

Introduction

James Lumley is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of three patents. His work focuses on developing compounds that address critical health issues.

Latest Patents

Among his latest patents are pharmaceutical compounds, specifically benzimidazoles, which are designed to inhibit respiratory syncytial virus (RSV) infections. These compounds feature complex chemical structures that allow for effective treatment options. Additionally, he has developed benzodiazepine derivatives aimed at treating hepatitis C infections. These derivatives utilize various chemical groups to enhance their efficacy in combating the virus.

Career Highlights

James Lumley has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Reviral Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Lumley has collaborated with esteemed colleagues such as Neil Mathews and Christopher Pilkington. These partnerships have fostered innovation and have been instrumental in advancing his research projects.

Conclusion

James Lumley's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His patents reflect a deep understanding of complex chemical interactions and their potential to treat serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…